PRESS RELEASES

CLINILABS TO PRESENT AT THE 44TH DIA ANNUAL MEETING

Boston, MA (June 16, 2008) – Clinilabs, Inc., a specialty contract research organization (CRO), will be exhibiting at the Drug Information Association’s (DIA) 44th Annual Meeting.  This event is scheduled to take place from June 22nd through the 26th at the Boston Convention and Exhibition Center in Boston, Massachusetts.

At this year’s Annual Meeting, Dr. Gary Zammit, President & CEO of Clinilabs, will be presenting a professional poster on “The Use of a Virtual Private Network (VPN) to Manage Global Clinical Trials: Analysis of Cost and Performance.” on June 24, from 9:30 AM to 5:30 PM.  Additionally, Lorraine Marchand, MBA, MA, COO of Clinilabs, will be presenting on “Building Effective Global Outsourcing Teams” on June 23rd, from 10:30 AM to 12:00 PM.

“DIA’s Annual Meeting is a great platform to showcase Clinilabs and its capabilities to a global audience of key industry professionals and partners from all sectors of the pharmaceutical industry,” stated Dr. Zammit.  “It also offers a wonderful opportunity to network globally and exchange information and ideas pertaining to drug development,” he added. 

Clinilabs will have on-site registration for its investigator database, the Company’s primary resource for identifying qualified investigators for participation in multicenter clinical trials.  Registering as an investigator provides a free Web-based investigator profile, notification of new clinical trial opportunities, free Web-based training for investigators and site staff, and free continuing education (CE) credits for completion of clinical research training modules.

DIA is a professional association with members from all over the world involved in the discovery, development, regulation, surveillance, or marketing of pharmaceuticals or related products.  Approximately 8,000 attendees, along with more than 500 companies and 1000 speakers are expected at the meeting.  

Visit Clinilabs at booth #1238 to learn more about our services and to sign up for our investigator database.  Also take part in our raffle for Nintendo’s Wii!

About Clinilabs, Inc.
Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics.  The Company also provides early phase services in a wider range of therapeutic areas at its Phase I facility.  Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in more than 10 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications.

Contact
For more information about Clinilabs and its exhibit, or to schedule an appointment with one of our representatives, please contact Jeanine Estrada at 212-981-2716 or via e-mail at jestrada@clinilabs.com.

For more information on DIA 2008 Annual Meeting or to register for the event, please call 215-442-6100, email dia@diahome.org, or visit www.diahome.org.